GO:0060415 muscle tissue morphogenesis: Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060415 muscle tissue morphogenesis is the biological process that generates and organizes the anatomical structures of muscle tissue, a contractile tissue composed of cells that are part of an organ.
• Muscle tissue morphogenesis depends on coordinated myogenic differentiation, fusion of myoblasts into multinucleated myofibers, and spatial organization of contractile sarcomeres.
• Signaling pathways such as TGF-β superfamily cues, IGF2, and FNIP1-TFEB signaling regulate muscle tissue formation and cross-talk with bone.
• Human pluripotent stem cell-derived organoids and 3D artificial skeletal muscles are powerful models to study myogenesis and muscle regeneration.
• Disruption of muscle tissue morphogenesis contributes to muscular dystrophies, sarcopenia, and impaired regeneration after injury.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal dissection of genes controlling muscle tissue morphogenesis.
Description
Muscle tissue morphogenesis (GO:0060415) is the developmental process in which the anatomical structures of muscle tissue are generated and organized. Muscle tissue consists of a set of cells that are part of an organ and carry out a contractile function, and its morphogenesis is essential for forming functional skeletal, cardiac, and smooth muscle. Understanding this process is fundamental for developmental biology, regenerative medicine, and disease modeling because defects in muscle tissue formation underlie congenital myopathies, muscular dystrophies, and age-related muscle loss. Recent advances in stem cell biology and tissue engineering have enabled researchers to recapitulate key steps of muscle tissue morphogenesis in vitro using human induced pluripotent stem cells (iPSCs) and organoid systems. These models, combined with CRISPR gene editing, allow precise interrogation of the genetic and signaling networks that control muscle tissue assembly. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0060415, its molecular players, and the methods used to study it.
muscle tissue morphogenesis At A Glance
| GO ID | GO:0060415 |
|---|---|
| GO term | muscle tissue morphogenesis |
| Ontology | biological_process |
| Synonym | none |
| Definition | The process in which the anatomical structures of muscle tissue are generated and organized. Muscle tissue consists of a set of cells that are part of an organ and carry out a contractive function. |
| Major function | Generation and spatial organization of contractile muscle tissue during development and regeneration |
| Related processes | Myogenesis, myoblast fusion, sarcomere assembly, muscle regeneration |
| Key signaling pathways | TGF-β superfamily, IGF2, FNIP1-TFEB, growth factor signaling |
| Representative models | Human iPSC-derived organoids, 3D artificial skeletal muscle, CRISPR-edited cell lines |
What Is GO:0060415?
According to the Gene Ontology, GO:0060415 muscle tissue morphogenesis is defined as the process in which the anatomical structures of muscle tissue are generated and organized. Muscle tissue consists of a set of cells that are part of an organ and carry out a contractive function. In practice, this encompasses the specification of myogenic progenitors, their differentiation and fusion into multinucleated myofibers, the assembly of contractile apparatus, and the spatial patterning that gives muscle tissue its characteristic architecture.
Why Is muscle tissue morphogenesis Important in Cell Biology?
Muscle tissue morphogenesis is central to the formation of all contractile organs and to the maintenance of muscle mass and function throughout life. Defects in this process cause or contribute to a wide range of human diseases, including congenital muscular dystrophies, sarcopenia, and impaired muscle regeneration after injury. Because muscle tissue also communicates with other tissues such as bone through secreted factors like IGF2, understanding its morphogenesis has broad implications for systemic physiology. Moreover, the ability to model muscle tissue morphogenesis in vitro using human iPSCs and organoids provides a platform for drug discovery and personalized medicine.
• Muscle tissue morphogenesis is required for normal development of skeletal, cardiac, and smooth muscle.
• Defects in myoblast fusion and sarcomere assembly lead to muscular dystrophies and congenital myopathies.
• Impaired muscle tissue morphogenesis contributes to sarcopenia and age-related muscle loss.
• Muscle-bone cross-talk via the FNIP1-TFEB-IGF2 axis links muscle morphogenesis to bone metabolism.
• TGF-β superfamily signaling temporally modulates muscle tissue morphogenesis and chondrogenesis.
• Human iPSC-derived artificial skeletal muscles enable modeling of muscular dystrophies and multilineage tissue engineering.
• Skeletal muscle organoids from human pluripotent stem cells model myogenesis and muscle regeneration.
• Growth factors are critical regulators of skeletal muscle tissue engineering and regeneration.
• Stem cell-based strategies offer therapeutic potential for skeletal muscle repair.
• CRISPR screening and gene editing accelerate discovery of causal genes in muscle morphogenesis.
What Happens During muscle tissue morphogenesis?
Myogenic specification and progenitor activation
In simple terms: Muscle stem cells are instructed to become muscle-forming cells.
Muscle tissue morphogenesis begins with the specification of myogenic progenitors from somitic or mesenchymal origins. Satellite cells, the resident muscle stem cells, self-renew and activate to generate myoblasts. This step is regulated by intrinsic transcriptional networks and extrinsic signals, including growth factors that promote myogenic commitment. In vitro, human pluripotent stem cells can be directed to form skeletal muscle organoids that recapitulate early myogenesis.
Myoblast differentiation and fusion
In simple terms: Muscle precursor cells fuse together to form long, multinucleated fibers.
Activated myoblasts exit the cell cycle, differentiate, and fuse to form multinucleated myofibers. This fusion process is essential for generating functional contractile units and is tightly controlled by membrane remodeling and cytoskeletal dynamics. Three-dimensional human iPSC-derived artificial skeletal muscles model this step and enable multilineage tissue engineering. Defects in fusion lead to impaired muscle tissue morphogenesis and are associated with muscular dystrophies.
Sarcomere assembly and contractile apparatus organization
In simple terms: The internal machinery that makes muscles contract is assembled and aligned.
Following fusion, myofibers assemble sarcomeres, the basic contractile units, and organize them into myofibrils. This structural organization is a hallmark of muscle tissue morphogenesis and requires coordinated expression of contractile proteins and their assembly into regular arrays. The spatial organization of muscle tissue is further refined by interactions with extracellular matrix and neighboring tissues.
Tissue patterning and cross-talk with adjacent tissues
In simple terms: Muscle tissue takes shape and communicates with nearby tissues like bone.
Muscle tissue morphogenesis involves spatial patterning that positions muscle groups correctly within the organ. Signaling cross-talk between muscle and bone, such as the FNIP1-TFEB-IGF2 axis, influences bone metabolism and systemic homeostasis. Temporal TGF-β superfamily signaling cues modulate tissue morphogenesis, including chondrogenesis within a muscle tissue model. These interactions ensure coordinated development of musculoskeletal tissues.
Regeneration and repair
In simple terms: After injury, muscle tissue can rebuild itself using stem cells.
In adult organisms, muscle tissue morphogenesis is recapitulated during regeneration. Satellite cells self-renew and differentiate to repair damaged myofibers. Stem cell-based strategies and growth factor delivery are being developed to enhance skeletal muscle tissue engineering and regeneration. Human skeletal muscle organoids provide a model to study myogenesis and muscle regeneration in vitro.
Key Genes Involved in GO:0060415 muscle tissue morphogenesis
The following genes and proteins are experimentally implicated in muscle tissue morphogenesis and related processes, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FNIP1 | Regulates TFEB and IGF2 signaling in muscle-bone cross-talk | Links muscle morphogenesis to bone metabolism |
| TFEB | Transcription factor downstream of FNIP1; controls IGF2 expression | Mediates muscle-bone cross-talk |
| IGF2 | Growth factor secreted by muscle; affects bone metabolism | Muscle-bone signaling axis |
| PAX7 | Satellite cell marker and regulator of self-renewal | Muscle stem cell biology |
| MYOD1 | Myogenic determination factor | Myoblast differentiation |
| MYOG | Myogenin; promotes myoblast fusion | Terminal differentiation |
| MYH | Myosin heavy chain; contractile protein | Sarcomere assembly |
| ACTA1 | Alpha-actin; core contractile protein | Sarcomere formation |
| TGFB1 | TGF-β superfamily ligand | Modulates tissue morphogenesis |
| BMP2 | Bone morphogenetic protein; TGF-β family member | Chondrogenesis within muscle model |
| IGF1 | Growth factor promoting myogenesis | Skeletal muscle tissue engineering |
| FGF2 | Fibroblast growth factor; regulates myoblast proliferation | Growth factor for muscle engineering |
| HGF | Hepatocyte growth factor; activates satellite cells | Muscle regeneration |
| VEGFA | Angiogenic factor; supports muscle vascularization | Tissue engineering |
| LAMA2 | Laminin subunit; extracellular matrix component | Muscular dystrophy modeling |
| DMD | Dystrophin; links cytoskeleton to matrix | Muscular dystrophy |
| COL1A1 | Collagen type I; matrix component | Muscle tissue engineering |
How Is muscle tissue morphogenesis Regulated?
Muscle tissue morphogenesis is regulated by a complex interplay of signaling pathways and transcription factors. The TGF-β superfamily, including TGF-β1 and BMP2, provides temporal cues that modulate tissue morphogenesis, including chondrogenesis within muscle tissue models. The FNIP1-TFEB-IGF2 axis mediates muscle-bone cross-talk and influences bone metabolism, highlighting systemic regulation. Growth factors such as IGF1, FGF2, and HGF promote myoblast proliferation, differentiation, and regeneration. Satellite cell self-renewal is controlled by intrinsic and extrinsic factors that balance quiescence and activation. These regulatory networks ensure proper muscle tissue formation and repair.
muscle tissue morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DMD | Duchenne muscular dystrophy | iPSC-derived skeletal muscle |
| LAMA2 | Congenital muscular dystrophy | 3D artificial muscle model |
| FNIP1 | Muscle-bone cross-talk; bone metabolism | Knockout mouse and human cells |
| IGF2 | Bone metabolism; muscle-bone axis | Overexpression and knockout models |
| MYOG | Myoblast fusion defects | CRISPR knockout in myoblasts |
Muscular dystrophies
Disruptions in muscle tissue morphogenesis contribute to muscular dystrophies, a group of genetic disorders characterized by progressive muscle weakness and degeneration. Human iPSC-derived artificial skeletal muscles have been used to model muscular dystrophies and enable multilineage tissue engineering. Defects in sarcomere assembly and myofiber stability are central to these conditions.
Sarcopenia and age-related muscle loss
Impaired muscle tissue morphogenesis and regeneration are hallmarks of sarcopenia, the age-related loss of muscle mass and function. Stem cell-based strategies aim to enhance muscle regeneration and counteract sarcopenia. Growth factor signaling is a key target for therapeutic intervention.
Muscle-bone disorders
Muscle-bone cross-talk through the FNIP1-TFEB-IGF2 axis is associated with bone metabolism in human and mouse. Dysregulation of this axis may contribute to osteoporosis and other musculoskeletal disorders, linking muscle tissue morphogenesis to bone health.
Congenital myopathies
Congenital myopathies often arise from mutations in genes controlling muscle tissue morphogenesis, including those involved in myoblast fusion and sarcomere assembly. Skeletal muscle organoids from human pluripotent stem cells provide a model to study these diseases and test therapeutic approaches.
From muscle tissue morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate myoblast fusion? | CRISPR knockout in human myoblasts |
| Does a point mutation in gene Y cause congenital myopathy? | Point mutation knock-in in iPSCs |
| Can overexpression of gene Z enhance muscle regeneration? | Overexpression in satellite cells |
| How does gene A affect muscle-bone cross-talk? | Knockout mouse and co-culture |
| What is the role of gene B in sarcomere assembly? | Tagged knock-in and imaging |
| Can CRISPR screening identify novel regulators of myogenesis? | Pooled CRISPR library in myoblasts |
How to Study the muscle tissue morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function phenotype | Identify essential genes in myogenesis |
| Point mutation knock-in | Effect of specific variants | Model congenital myopathies |
| Tagged knock-in | Protein localization and dynamics | Live imaging of sarcomere assembly |
| Overexpression | Gain-of-function phenotype | Enhance regeneration or model disease |
| RNA-seq | Transcriptional changes | Profile myogenic differentiation |
| Proteomics | Protein expression and interactions | Identify sarcomere components |
| Imaging (confocal, live-cell) | Morphology and dynamics | Analyze myoblast fusion and sarcomere organization |
| Organoid culture | 3D tissue morphogenesis | Model muscle development and disease |
CRISPR knockout and point mutation
CRISPR-Cas9 knockout and point mutation are used to test the causal role of genes in muscle tissue morphogenesis. Knockout of myogenic regulators in human iPSCs or myoblasts can reveal defects in differentiation and fusion. Point mutations can model patient-specific variants associated with muscular dystrophies.
Knock-in and tagged knock-in
Knock-in of fluorescent or epitope tags allows visualization of endogenous proteins during muscle tissue morphogenesis. Tagged knock-in of sarcomeric proteins enables live imaging of sarcomere assembly. Knock-in of disease mutations recapitulates pathological phenotypes in vitro.
Overexpression and gain-of-function studies
Overexpression of growth factors or transcription factors can enhance or perturb muscle tissue morphogenesis. For example, IGF2 overexpression affects muscle-bone cross-talk. Growth factor supplementation is used in skeletal muscle tissue engineering.
Organoid and 3D tissue models
Human pluripotent stem cell-derived skeletal muscle organoids and 3D artificial muscles model myogenesis and muscle regeneration. These systems allow spatial and temporal analysis of muscle tissue morphogenesis and enable multilineage tissue engineering.
How CRISPR Can Be Used to Study GO:0060415 muscle tissue morphogenesis
Knockout
CRISPR knockout is used to ablate genes suspected to regulate muscle tissue morphogenesis. For example, knocking out MYOG in human myoblasts impairs fusion and differentiation. Knockout models help establish causality between a gene and a morphogenetic step.
Point Mutation
Point mutation knock-in introduces specific patient variants to model disease-associated changes in muscle tissue morphogenesis. This approach is valuable for studying congenital myopathies and muscular dystrophies.
Knock-in
Knock-in of reporter tags or disease alleles allows tracking of endogenous proteins and recapitulation of pathological phenotypes. Tagged knock-in of sarcomeric proteins enables visualization of sarcomere assembly in real time.
Overexpression
CRISPR activation or cDNA overexpression is used to increase expression of genes that promote muscle tissue morphogenesis, such as growth factors. Overexpression models can reveal sufficiency of a gene to drive morphogenetic processes.
How EDITGENE Supports muscle tissue morphogenesis Research
Researchers studying muscle tissue morphogenesis-related genes often need to determine whether a candidate gene is causally involved in myoblast fusion, sarcomere assembly, or tissue patterning. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this discovery process, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for muscle tissue morphogenesis research.
Frequently Asked Questions About muscle tissue morphogenesis
What is GO:0060415 muscle tissue morphogenesis?
GO:0060415 is the biological process in which the anatomical structures of muscle tissue are generated and organized, as defined by the Gene Ontology.
What genes are involved in muscle tissue morphogenesis?
Key genes include FNIP1, TFEB, IGF2, PAX7, MYOD1, MYOG, and sarcomeric proteins like MYH and ACTA1.
How is muscle tissue morphogenesis regulated?
It is regulated by TGF-β superfamily signaling, growth factors, and the FNIP1-TFEB-IGF2 axis.
What diseases are associated with defects in muscle tissue morphogenesis?
Muscular dystrophies, congenital myopathies, sarcopenia, and muscle-bone disorders.
What models are used to study muscle tissue morphogenesis?
Human iPSC-derived organoids, 3D artificial skeletal muscles, and CRISPR-edited cell lines.
How can CRISPR help study muscle tissue morphogenesis?
CRISPR knockout, point mutation, knock-in, and overexpression enable causal testing of genes in myogenesis.
What is the role of satellite cells in muscle tissue morphogenesis?
Satellite cells self-renew and differentiate to form myofibers during development and regeneration.
How does muscle tissue communicate with bone?
Through the FNIP1-TFEB-IGF2 axis, muscle secretes IGF2 which affects bone metabolism.
What are skeletal muscle organoids?
They are 3D structures derived from human pluripotent stem cells that model myogenesis and muscle regeneration.
Why is muscle tissue morphogenesis important for regenerative medicine?
Understanding it enables development of stem cell-based therapies for muscle repair and diseases like muscular dystrophy.
Conclusion
GO:0060415 muscle tissue morphogenesis is a fundamental biological process that governs the formation and organization of contractile muscle tissue. Its regulation by signaling pathways such as TGF-β superfamily and the FNIP1-TFEB-IGF2 axis, and its disruption in diseases like muscular dystrophies and sarcopenia, make it a critical area of research. Advances in human iPSC-derived organoids and CRISPR gene editing provide powerful tools to dissect the genetic and molecular mechanisms underlying muscle tissue morphogenesis. EDITGENE offers comprehensive CRISPR services to support these investigations and accelerate therapeutic discovery.
References
- 1. Mao Y et al.. 2024. Muscle-bone cross-talk through the FNIP1-TFEB-IGF2 axis is associated with bone metabolism in human and mouse.. Sci Transl Med 16(750):eadk9811 PMID: 38838134
- 2. Giordani L et al.. 2018. Satellite Cell Self-Renewal.. Curr Top Dev Biol 126:177-203 PMID: 29304998
- 3. Maffioletti SM et al.. 2018. Three-Dimensional Human iPSC-Derived Artificial Skeletal Muscles Model Muscular Dystrophies and Enable Multilineage Tissue Engineering.. Cell Rep 23(3):899-908 PMID: 29669293
- 4. Xiong F et al.. 2025. Parallel Chondrogenesis and Osteogenesis Tissue Morphogenesis in Muscle Tissue via Combinations of TGF-β Supergene Family Members.. Cartilage 16(1):71-88 PMID: 37714817
- 5. Shin MK et al.. 2022. Generation of Skeletal Muscle Organoids from Human Pluripotent Stem Cells to Model Myogenesis and Muscle Regeneration.. Int J Mol Sci 23(9) PMID: 35563499
- 6. Baldwin C et al.. 2022. Stem cell-based strategies for skeletal muscle tissue engineering.. J Tissue Eng Regen Med 16(12):1061-1068 PMID: 36223074
- 7. Syverud BC et al.. 2016. Growth Factors for Skeletal Muscle Tissue Engineering.. Cells Tissues Organs 202(3-4):169-179 PMID: 27825154
- 8. Xiong F et al.. 2020. Temporal TGF-β Supergene Family Signalling Cues Modulating Tissue Morphogenesis: Chondrogenesis within a Muscle Tissue Model?. Int J Mol Sci 21(14) PMID: 32660137
